Paid Clinical Trials Idaho

Discover 345 paid clinical trials in Idaho. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 345

A Switch Study From High-Sodium Oxybate to XYWAV to Evaluate Changes in Blood Pressure in Participants With Narcolepsy

Recruiting

Sponsor:

Jazz Pharmaceuticals

Location:

Nampa, Portland, Las Vegas, Hendersonshow 29 more

Code:

NCT05869773

Conditions

Narcolepsy

Eligibility Criteria

Sex: All

Age: 18 - 70

Healthy Volunteers: Not accepted

Interventions

JZP258

Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Effects of EP262 in Subjects With Chronic Spontaneous Urticaria

Recruiting

PHASE2

Sponsor:

Escient Pharmaceuticals, Inc

Location:

Boise, Missoula, Murray, North Las Vegasshow 32 more

Code:

NCT06077773

Conditions

Chronic Spontaneous Urticaria

Eligibility Criteria

Sex: All

Age: 18 - 70+

Healthy Volunteers: Not accepted

Interventions

Oral EP262

Placebo

Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors

Recruiting

PHASE2

Sponsor:

National Cancer Institute (NCI)

Location:

Boise, Emmett, Meridian, Nampashow 350 more

Code:

NCT03866382

Conditions

Bladder Adenocarcinoma

Bladder Clear Cell Adenocarcinoma

Bladder Mixed Adenocarcinoma

Bladder Neuroendocrine Carcinoma

Bladder Small Cell Neuroendocrine Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Biospecimen Collection

Bone Scan

Cabozantinib S-malate

Computed Tomography

Echocardiography

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

Recruiting

PHASE2

Sponsor:

SWOG Cancer Research Network

Location:

Boise, Nampa, Caldwell, Ontarioshow 69 more

Code:

NCT06116682

Conditions

Lung Non-Small Cell Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Amivantamab

Biospecimen Collection

Computed Tomography

Magnetic Resonance Imaging

A Study to Assess Change in Disease Activity and Adverse Events of Oral Upadacitinib in Adult and Adolescent Participants With Moderate to Severe Hidradenitis Suppurativa Who Have Failed Anti-TNF Therapy

Recruiting

PHASE3

Sponsor:

AbbVie

Location:

Boise, Spokane, Murray, Portlandshow 71 more

Code:

NCT05889182

Conditions

Hidradenitis Suppurativa

Eligibility Criteria

Sex: All

Age: 12+

Healthy Volunteers: Not accepted

Interventions

Upadacitinib

Placebo

A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults with Chronic Inducible Urticaria

Recruiting

PHASE2

Sponsor:

Evommune, Inc.

Location:

Boise, Los Angeles, San Diego, Fargoshow 12 more

Code:

NCT06603220

Conditions

Chronic Inducible Urticaria

Eligibility Criteria

Sex: All

Age: 18 - 65

Healthy Volunteers: Not accepted

Interventions

Oral EVO756

LMN-201 for Prevention of C. Difficile Infection Recurrence

Recruiting

PHASE2

PHASE3

Sponsor:

Lumen Bioscience, Inc.

Location:

Idaho Falls, Butte, Los Angeles, Omahashow 11 more

Code:

NCT05330182

Conditions

Clostridioides Difficile Infection

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

LMN-201

Placebo

Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors

Recruiting

PHASE2

Sponsor:

SWOG Cancer Research Network

Location:

Boise, Meridian, Nampa, Twin Fallsshow 210 more

Code:

NCT05040360

Conditions

Metastatic Malignant Neoplasm in the Liver

Pancreatic Neuroendocrine Tumor

Stage I Pancreatic Neuroendocrine Tumor AJCC v8

Stage II Pancreatic Neuroendocrine Tumor AJCC v8

Stage III Pancreatic Neuroendocrine Tumor AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Capecitabine

Temozolomide

A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002)

Recruiting

PHASE3

Sponsor:

Merck Sharp & Dohme LLC

Location:

Post Falls, Billings, Corvallis, Colorado Springsshow 33 more

Code:

NCT06077760

Conditions

Non-small Cell Lung Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

V940

Pembrolizumab

Placebo

Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer

Recruiting

PHASE3

Sponsor:

National Cancer Institute (NCI)

Location:

Boise, Emmett, Meridian, Nampashow 395 more

Code:

NCT04181060

Conditions

Advanced Lung Non-Squamous Non-Small Cell Carcinoma

Metastatic Lung Non-Squamous Non-Small Cell Carcinoma

Recurrent Lung Non-Squamous Non-Small Cell Carcinoma

Stage IIIB Lung Cancer AJCC v8

Stage IV Lung Cancer AJCC v8

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Bevacizumab

Biospecimen Collection

Computed Tomography

Echocardiography

Magnetic Resonance Imaging

Popular cities in Idaho

Meridian Boise